Airway Clearance Devices Market Size By Device Type (Oscillatory Positive Expiratory Pressure (OPEP), High Frequency Chest Wall Oscillation (HFCWO)), By Application (Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis), By End-use, & Forecast, 2023 – 2032

Airway Clearance Devices Market Size

Airway Clearance Devices Market size was valued at around USD 605 million in 2022 and is projected to reach over USD 1 billion by 2032. The increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disorder (COPD), cystic fibrosis, and bronchiectasis is a significant driver for the market.
 

According to the survey of the United States Medicare, in 2022, around estimated 350,000 to 500,000 individuals in the U.S. suffer from bronchiectasis. This prevalence surges with age with around 8- to 10-fold difference in prevalence among adults aged 60 years & above. Reports from European countries such as the UK and Germany highlights similar differences in prevalence. Also, the rising awareness about these conditions and the need for effective airway clearance therapies have led to an increased demand for these devices. Moreover, the technological advancements in airway clearance devices are further contributing to the market progress.
 

Airway clearance devices are medical devices designed to assist in clearing mucus, secretions, and other materials from the airways of individuals with respiratory conditions such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and asthma. These devices play a crucial role in improving lung function, reducing the risk of respiratory infections, and enhancing overall respiratory health.
 

However, the lack of awareness among the general populace regarding cystic fibrosis & its therapeutic alternatives, particularly airway clearance devices may impede the business growth. Many people are unaware that these devices exist as a treatment option for respiratory conditions such as COPD, cystic fibrosis, bronchiectasis, etc. This lack of awareness is owing to the limited use and knowledge, as these devices are relatively new & are not widely adopted in clinical practice. Also, the limited public education campaigns and initiatives specifically targeting cystic fibrosis may result in insufficient knowledge and understanding among the general population. Additionally, insufficient government support or funding for cystic fibrosis awareness programs and research can be a significant constraint, further limiting the market growth prospects.
 

COVID-19 Impact

The emergence of COVID-19 is an unprecedented public health concern that had negatively affected the airway clearance devices market expansion. Nation-wide lockdowns, and emergencies were imposed in various countries and maintaining crucial medical resources was given priority owing to COVID-19. The medical professionals and specialists were instructed to address only the emergency and critical surgical operations. These developments enforced delays or suspension in the routine care by several healthcare settings, including respiratory care practice. This limitation has affected patients' ability to receive in-person assessments, training, and support for airway clearance device use. Moreover, the homecare services, including respiratory therapy and support for airway clearance devices was impacted due to the pandemic.
 

Airway Clearance Devices Market Trends

The increasing prevalence of multiple respiratory conditions such as cystic fibrosis, neuromuscular, bronchiectasis, immotile cilia syndrome, etc. is expected to drive the market growth. This surge in respiratory conditions has created a strong demand for effective management and treatment options, including airway clearance devices. As per the Global Burden of Disease Study, in 2018, respiratory diseases were ranked the third leading cause of death globally, accounting for 10.8% of all deaths. The WHO estimates also state that the COPD, in particular, affects approximately 384 million people worldwide, as of 2021. This increasing prevalence of respiratory conditions is set to drive the adoption of airway clearance devices.

The growing prevalence of respiratory disorders, coupled with increasing awareness, diagnosis rates, and the emphasis on personalized care, has fueled the demand for airway clearance devices. The global market is projected to experience substantial growth in the coming years. Businesses operating in this sector have an opportunity to meet the needs of a growing patient population by offering innovative, user-friendly, and homecare-compatible airway clearance devices. By addressing the rising demand for respiratory care, businesses in the market can contribute to improved patient outcomes and enhanced quality of life for individuals living with respiratory disorders.

Airway Clearance Devices Market Analysis

Based on device type, the airway clearance devices market is segmented as oscillatory positive expiratory pressure (O-PEP), high frequency chest wall oscillation (HFCWO), intrapulmonary percussive ventilation (IPV), and others. High frequency chest wall oscillation (HFCWO) segment accounted for USD 183.7 million in 2022 and is expected to reach USD 313.2 million by 2032. This considerable revenue share is attributable to the multiple benefits related to the use of HFCWO in airway clearance therapies. This technique employs the use of a mechanical devices to apply rapid oscillations or vibrations to the chest wall, helping to loosen & mobilize mucus, making it easier to clear from the airway. This can lead to improved lung function and reduced risk of respiratory infections. These devices commonly allow customizable settings, such as adjusting the frequency and intensity of oscillations. This enables healthcare providers to modify the treatment to the specific needs of each patient. HFCWO sessions can provide a consistent and standardized treatment approach compared to some other airway clearance techniques.
 

Based on application, the airway clearance devices market is segmented as chronic obstructive pulmonary disease, cystic fibrosis, bronchiectasis, neuromuscular, and others. The cystic fibrosis segment accounted for the considerable revenue share in 2022 and is expected to propel at a 5.4% CAGR from 2023-2032. This market share is due to the high prevalence & incidence rates associated with this condition. The increasing prevalence of cystic fibrosis is a major growth driver for the market. Cystic fibrosis (CF) has traditionally been defined as the most common life-threatening inherited disorder. According to the Cystic Fibrosis Foundation, in 2020, an estimated 70,000 people worldwide are living with cystic fibrosis. Additionally, advancements in medical care and increased life expectancy have contributed to a growing adult cystic fibrosis population. This expansion in the patient pool underscores the need for effective airway clearance devices.
 

Based on end-use, the airway clearance devices market is segmented as hospitals, homecare settings, and others. The homecare settings segment accounted for majority revenue share and was valued at over USD 377 million in 2022. This significant segment growth is majorly attributed to the surging patient preference for the use of airway clearance devices in homecare settings. The trend towards providing respiratory care in home settings has gained momentum, driven by factors such as patient convenience, cost-effectiveness, and the desire to reduce hospital readmissions.
 

Airway clearance devices that are portable, user-friendly, and suitable for home use have experienced a surge in demand. The ability for patients to self-manage their respiratory conditions with proper training and guidance further contributes to market growth. Also, the development of easy to use & convenient airway clearance devices is further set to drive its adoption in the homecare settings that is anticipated to boost the market size.
 

The U.S. airway clearance devices market is predicted to reach over USD 288 million by 2032. This dominant market growth is primarily owing to several variables including the high disease burden of respiratory conditions, rise in awareness regarding airway clearance devices, and supportive legislative policies in the country. For instance, as per the American Lung Association, in 2018, approximately 9 million adults, or 3.6% of individuals aged 18 or above were suffering from chronic bronchitis in the U.S. Similarly, around 2 million adults were suffering from emphysema. These statistics indicate substantial market expansion opportunity for key players operating in this industry. Moreover, facilitative healthcare policies and reimbursement frameworks that support the use of airway clearance devices in cystic fibrosis management also contribute to market progress.
 

Airway Clearance Devices Market Share

Some of the major players operating in the airway clearance devices market

• Hill-Rom Holdings, Inc./Baxter
• Koninklijke Philips N.V.
• Tactile Medical
• Thayer Medical
• Electromed Inc.
• Mercury Medical
• VORTRAN Medical Technology 1 Inc.
• Monaghan Medical Corporation
• Pari Medical Holding GmbH
• Dymedso Inc.
• Med Systems Inc.
• Vyaire Medical, Inc.
• Smiths Medical,Inc (ICU Medical)

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion.
 

Airway Clearance Devices Industry Leaders:

• In December 2022, Electromed announced the U.S. FDA clearance of Smartvest Clear way, Airway clearnce device that is designed for high frequency chest wall oscillation (''HFCWO'') therapy. This helped the company to introduce innovative products, further offering a competitive edge over its competitors.
   
• In January 2022, ICU Medical Inc. announced the acquisition of Smiths Medical from Smiths Group plc, a manufacturer of respiratory management devices and other advance medical devices. This acquisition helped the company to increase their product portfolio and acquire new customer base. Moreover, in May 2020, Vyaire Medical announced a strategic partnership with Spirit AeroSystems Inc. to boost the production of respiratory products and devices during the COVID-19 pandemic. This strategic partnership helped the company to increase their market presence and enhance their business revenue.

Airway clearance devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Device type, 2018 - 2032 (USD Million)

• Oscillatory Positive Expiratory Pressure (O-PEP)
• High Frequency Chest Wall Oscillation (HFCWO)
• Intrapulmonary Percussive Ventilation (IPV)
• Others                                              

By Application, 2018 - 2032 (USD Million)

• Chronic Obstructive Pulmonary Disease (COPD)
• Bronchiectasis
• Cystic Fibrosis
• Neuromuscular
• Others

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Homecare Settings
• Others  

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Switzerland
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt
  • Turkey